TEAM.NASDAQAtlassian CORP

Form 4: Atlassian Co-Founder Sells $1.22M in Stock

Sentiment:

Insider Transaction Report


Atlassian co-founder and 10% owner Scott Farquhar sold 7,665 shares of Class A Common Stock for approximately $1.22 million through a pre-arranged trading plan.

Summary

  • Scott Farquhar, a Director and 10% owner of Atlassian Corp (TEAM), reported the sale of Class A Common Stock.
  • A total of 7,665 shares were disposed of on September 30, 2025.
  • The transactions were executed at weighted-average prices ranging from $158.2473 to $164.3467 per share.
  • The total value of the shares sold amounts to approximately $1,223,538.65.
  • These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Farquhar on February 12, 2025.
  • All shares sold were indirectly held by Farquhar Investment Partnership No. 2, and following these transactions, the indirect beneficial ownership through this entity is 0.00 shares.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to a significant insider sale by a co-founder, although the pre-arranged 10b5-1 plan mitigates the immediate negative interpretation of discretionary selling.

Positives

  • The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a scheduled sale rather than a discretionary one based on immediate market views.

Negatives

  • A significant insider sale by a co-founder and 10% owner could be perceived as a negative signal by some investors, despite being pre-planned.
  • The reduction of indirect beneficial ownership to zero through Farquhar Investment Partnership No. 2 represents a complete divestment of that specific holding.

Risks

  • No specific risks were mentioned in the filing beyond the general implications of insider selling.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Trading Plan AdoptionScott Farquhar adopted a Rule 10b5-1 trading plan on February 12, 2025, which governed these stock sales.02/12/2025A 10b5-1 plan allows insiders to sell shares at a pre-determined time or price, providing an affirmative defense against insider trading allegations and promoting transparency in insider transactions.

Related Party Transactions

  • The shares sold were indirectly held by Farquhar Investment Partnership No. 2, which is a related entity to the reporting person, Scott Farquhar.

Stakeholder Impact

  • Shareholders may interpret the insider sale as a signal, potentially influencing their perception of the company's stock value, though the 10b5-1 plan suggests a non-discretionary sale.

Key Dates

DateDescription
02/12/2025Rule 10b5-1 trading plan adopted by Scott Farquhar.
09/30/2025Date of Class A Common Stock transactions.

Recommendation

hold

The filing details a pre-scheduled insider sale by a co-founder under a Rule 10b5-1 plan. While insider selling can sometimes be a negative signal, sales under a 10b5-1 plan are typically for personal financial planning or diversification and do not necessarily reflect a change in the insider's view of the company's future prospects. Therefore, this transaction alone is not a strong indicator for a 'buy' or 'sell' recommendation, warranting a 'hold' position for investors to await further fundamental company updates.

Keywords

Atlassian, TEAM, Scott Farquhar, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.